A polyposis register has been established in the Northern Region of England. A total of 48 families with 71 living affected subjects has been identified during the first three years ofoperation, a prevalence of 2*29x 1i. Indirect ophthalmoscopy identifies the majority of gene carriers by showing multiple areas of congenital hypertrophy of the retinal pigment epithelium (CHRPE). The absence of this sign in families limits its value where a relative with CHRPE has not been identified. Combining eye examination with data on age of onset and linked DNA markers is highly effective in carrier exclusion; 38% of 528 first, second, and third degree relatives had their carrier risk reduced to less than 1 in 1000. Even with such assurance many subjects will request continued bowel screening at a reduced
Familial adenomatous polyposis coli (FAPC) is a common autosomal dominant disorder characterised by multiple adenomatous polyps which develop, in particular, in the large bowel and show a marked propensity to malignant transformation. Following the recognition of its hereditary nature and the value of elective resection of the colon, diagnostic surgical registers began to develop. The first among these was the register at St Mark's Hospital, London where for over 50 years relatives at risk have been screened for the development of polyps by annual sigmoidoscopy. ' The potential for manifestation of the disorder up to middle age has led to the adoption of a policy of bowel examination up to the age of 50 years. When polyps develop, elective resection of the colon with ileorectal anastomosis and surveillance of the rectum2 is preferred generally to panproctocolectomy, which has the disadvantage of sphincter loss, and the ileal pouch,3 which is associated with a greater degree of surgical morbidity.
Adenomata in the upper gastrointestinal tract may undergo malignant change, particularly at the ampulla of Vater. 4 Desmoid tumours of the abdomen constitute a rare but major complication,5 as do the occasional development of malignancies at other sites, including thyroid papillary adenocarcinomata, central nervous system tumours, and hepatoblastomata. 8 Benign osteomata together with sebaceous cysts and intestinal polyps form the triad known as Gardner's syndrome.9 Recent molecular genetic evidence offers support to the clinical belief that Gardner's syndrome and FAPC are phenotypic variants of the same genetic defect.'0 Cases of FAPC with brain tumours should not, however, be confused with the phenotypically distinct, and probably autosomal recessive, Turcot's syndrome. "
The gene for FAPC was localised to 5q21 in 198712 and a variety of increasingly close polymorphic DNA markers have since become available.'0 13 r4This has raised the possibility of exclusion of carrier status in family members without the need for annual bowel examination until middle age. For this to be effective, however, complete ascertainment and an understanding of probability calculation have become essential.
A clinical development of major relevance to the calculation of carrier risk has been the recognition of multiple areas of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in heterozygotes. First identified in Gardner's syndrome,'5 several studies have described it in FAPC regardless of other extracolonic features.'621 The present study shows the clinical relevance of this sign and molecular genetic advances in a defined geographical population as a guide to the formation of effective genetic registers, which may bring about a significant reduction in the morbidity and mortality associated with this important disorder.
Materials and methods
The Northern Regional Health Authority serves a population of 3-1 million people with relatively little migration. There are two urban concentrations around Tyneside and Teeside comprising approximately two-thirds of the population. A registry of polyposis families was established in 1987 by the Northern Region Genetics Advisory Service in collaboration with the surgeons in the region. Under the direction of a consultant surgeon (AG) and the consultant clinical geneticist (JB), a genetic nurse (PC) was appointed to identify and visit all families known to have, or have had, a member with FAPC. With the active assistance of the region's 72 surgeons, the records of the surgical units were reviewed to identify FAPC patients known to them, and relatives who were being regularly screened. Seminars and lectures were instituted in the district hospitals to improve ascertainment.
In order to establish the value of ophthalmological examiination, 66 affected subjects have been examined by indirect ophthalmoscopy after pupil dilatation by one of two ophthalmologists (CW and WC). Ninetyfour adult controls were also examined. Indirect fundoscopy produces a wider field of view than direct, though it requires a greater level of operator skill. In order to assess interobserver error, the first 20 in each group were examined separately by the two ophthalmologists. Despite mydriasis lasting up to four hours the investigation was well tolerated. The need to hold a direction of gaze for several seconds limits use in young children.
Blood samples were obtained from available family members for analysis of linked polymorphic DNA markers. Principal use of the probes Pi227 and C lPIl was made during the first two years of study. Subsequently, the markers YN5.48 and ECB27 were added to the analysis.
The probability that family members carried the gene for FAPC was estimated in each case using traditional Bayesian calculation taking as conditional probabilities the age at which rigid sigmoidoscopy had proved normal, the results of eye examination, and, where informative, the results of DNA analysis.
In order to assess the likely impact of screening and perceptions of the disease together with attitudes to prenatal diagnosis and reassurance based on probability calculations, a group of gene carriers and their first degree relatives completed an attitude questionnaire. A practical guide in terms of register planning and audit would be that the incidence of FAPC is likely to be 1 in 10 000 and the point prevalence rate for manifesting carriers should be at least 1 in 30 000.
EYE EXAMINATION
Our experience with indirect ophthalmoscopy as a means of carrier detection was very favourable, with only 7-6% of obligate carriers having fewer than three lesions, while none of the controls exceeded this number. In other series occasional controls had four lesions and very rarely five lesions. In practice, therefore, first degree relatives were regarded as definite gene carriers if they had six or more, or if they displayed the typical large lesions, ranging up to one disc diameter, and with hypopigmented and hyperpigmented areas. If a first degree relative had fewer than four 'dots' on examination by one of our two experienced ophthalmologists, a conservative conditional probability of 1 in 10 was assigned. In centres without a large local series, a negative investigation must be regarded with more caution. In our series of obligate carriers, examination of 20 cases was performed by two independent ophthalmologists and the resulting fundal diagrams were almost identical. The ophthalmologists were not given clinical details before examination. Indirect fundoscopy does require considerable skill, however, and it is essential that ophthalmologists are aware of the need to record every lesion. In our series, the ratio of tiny lesions described as 'dots' to larger lesions was 2 to 1. The ratio of lesions inside a circle with a half radius compared to the number outside that line in the retinal periphery was 1:3, that is, most lesions are at the edges and most are small. These ratios may be used to compare with retinal charts provided by other ophthalmologists. Ideally, all eye examinations should be performed by a single ophthalmologist in each region who should have an opportunity to examine a series of obligate carriers before starting formal screening of a high risk population for counselling purposes.
Traboulsi et al'9 found multiple CHRPEs in 86-4% of gene carriers in 23 pedigrees, whereas five subjects from the three remaining pedigrees were negative for this sign. Romania et al20 found diagnostic numbers of retinal lesions in all 61 affected members of 34 pedigrees, with a range of four to 64. In the other 18 kindreds, which had a later mean age of onset, 32 patients were examined and none had more than three eye lesions. Polkinghorne et a12' found only 2/72 definite APC carriers to have no retinal lesions, but a relatively small proportion (62 5%) had six or more lesions. When morphology was added, however, at least 80% of their series could be assigned to the carrier group. They did not report an analysis of familial aggregation of the eye signs.
Thus, in a minority of FAP families, whose proportion of the total shows geographical variation, CHRPE lesions are consistendy absent and in such families eye examination does not contribute to risk calculation. There is a suggestion that the presence of CHRPEs and possibly their total number is a reflection of a more aggressive form of the disease and there is a milder CHRPE negative form which may merge into the non-polyposis dominant colorectal cancer category. This is likely to be allelic in some cases in view of the recent observation of 5q allele loss in sporadic colon cancers.32
OTHER EXTRACOLONIC FEATURES
There was no evidence in the present analysis to support a clinical distinction between FAPC and Gardner's syndrome. The use of orthopantomograms to detect jaw cysts has been put forward as a screening investigation,33 though it presents problems with considerable interobserver error34 and, in consequence, has not been used routinely in our register. AUDIT FAPC lends itself to audit by comparison of the number of families and persons known to each region. Ultimately, the success of regional registers may be measured on the basis of life expectancy. The dramatic increase in the number of relatives under surveillance in the Northern Region should have an impact, since retrospective analysis showed that of patients detected by screening only 1/25 (4%) had malignancy whereas among those detected on the basis of symptoms, 10/31 (32-3%) had a colorectal malignancy.35 There is some prospective evidence of benefit; seven severely affected subjects, one of whom had carcinoma in situ, would not have undergone surgery had it not been for the genetic nurse. One case history illustrates the importance of a domiciliary family visitor. A 21 year old man had refused bowel examination despite being at 50% risk. His denial reaction was only overcome by some 40 hours of domiciliary contact. During this process he agreed to eye examination which showed multiple CHRPEs. 
